[144] Alphabet Inc. SEC Filing

Rhea-AI Filing Summary

Alphabet Inc. (GOOGL) Form 144 notice outlines proposed sales of Class C common stock. The filer reports an intended sale of 4,000 Class C shares through Morgan Stanley Smith Barney with an aggregate market value of $809,960 and an approximate sale date of 08/20/2025 on NASDAQ. The 4,000 shares were acquired as Restricted Stock Units on 04/25/2018 from the issuer and were paid for on that date. The filing also lists multiple recent 10b5-1 sales by Sundar Pichai and the Pichai Family Foundation between 05/21/2025 and 08/06/2025, including recurring blocks of 32,500 and 4,000 Class C shares with reported gross proceeds for each trade.

Positive

• Transparent disclosure of the proposed 4,000 share sale and recent 10b5-1 trades by named insiders
• Acquisition details provided: the 4,000 shares were acquired as Restricted Stock Units on 04/25/2018

Negative

• None.

Insights

Securities Analyst

TL;DR Routine insider planned sale under Rule 144 and multiple recent 10b5-1 dispositions by the CEO and related foundation; appears procedural.

The filing documents a proposed sale of 4,000 Class C shares acquired as RSUs in 2018, to be executed through Morgan Stanley Smith Barney on NASDAQ. The record of repeated 10b5-1 trades by Sundar Pichai and the Pichai Family Foundation across multiple dates with material gross proceeds indicates ongoing systematic dispositions rather than ad hoc large one-time sales. No new material corporate events, changes in ownership percentage, or unusual trading arrangements are disclosed in this notice.

Corporate Governance Expert

TL;DR Compliance disclosure consistent with Rule 144 and 10b5-1 activity; reinforces adherence to planned trading programs.

The form specifies acquisition method (Restricted Stock Units) and confirms representation regarding material non-public information. The filing provides dates and amounts for recent sales by the named individuals/entities, supporting transparency of insider liquidity. There are no statements here about plan adoption dates or material non-public information, and no indications of departures from standard insider trading protocols.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Class C	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	4000	809960.00	5430000000	08/20/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Class C	04/25/2018	Restricted Stock Units	Issuer			4000	04/25/2018	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for PICHAI FAMILY FOUNDATION 1600 Amphitheatre Parkway Mountain View CA 94043	Common Class C	08/06/2025	4000	784810.40
10b5-1 Sales for SUNDAR PICHAI 1600 Amphitheatre Parkway Mountain View CA 94043	Common Class C	08/06/2025	32500	6377416.50
10b5-1 Sales for PICHAI FAMILY FOUNDATION 1600 Amphitheatre Parkway Mountain View CA 94043	Common Class C	07/16/2025	4000	737474.00
10b5-1 Sales for SUNDAR PICHAI 1600 Amphitheatre Parkway Mountain View CA 94043	Common Class C	07/16/2025	32500	5992187.50
10b5-1 Sales for PICHAI FAMILY FOUNDATION 1600 Amphitheatre Parkway Mountain View CA 94043	Common Class C	07/02/2025	4000	714089.60
10b5-1 Sales for SUNDAR PICHAI 1600 Amphitheatre Parkway Mountain View CA 94043	Common Class C	07/02/2025	32500	5801978.00
10b5-1 Sales for PICHAI FAMILY FOUNDATION 1600 Amphitheatre Parkway Mountain View CA 94043	Common Class C	06/18/2025	4000	706904.40
10b5-1 Sales for SUNDAR PICHAI 1600 Amphitheatre Parkway Mountain View CA 94043	Common Class C	06/18/2025	32500	5742122.75
10b5-1 Sales for PICHAI FAMILY FOUNDATION 1600 Amphitheatre Parkway Mountain View CA 94043	Common Class C	06/04/2025	4000	674870.00
10b5-1 Sales for SUNDAR PICHAI 1600 Amphitheatre Parkway Mountain View CA 94043	Common Class C	06/04/2025	32500	5483234.25
10b5-1 Sales for PICHAI FAMILY FOUNDATION 1600 Amphitheatre Parkway Mountain View CA 94043	Common Class C	05/21/2025	4000	683184.80
10b5-1 Sales for SUNDAR PICHAI 1600 Amphitheatre Parkway Mountain View CA 94043	Common Class C	05/21/2025	32500	5553297.75

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filing for GOOGL report?

The filing reports a proposed sale of 4,000 Class C shares via Morgan Stanley Smith Barney with an aggregate market value of $809,960 and an approximate sale date of 08/20/2025.

Who acquired the securities being sold and how were they acquired?

The 4,000 Class C shares were acquired as Restricted Stock Units on 04/25/2018 from the issuer.

Does the filing show recent insider sales for GOOGL?

Yes. The filing lists multiple 10b5-1 sales by Sundar Pichai and the Pichai Family Foundation from 05/21/2025 through 08/06/2025, including recurring blocks of 32,500 and 4,000 shares.

What broker is handling the proposed sale?

The proposed sale is to be handled by Morgan Stanley Smith Barney LLC at the address provided in the filing.

Are there any statements about material non-public information in the filing?

The filer represents by signing the notice that they do not know any material adverse information about the issuer that has not been publicly disclosed.